Supportive Care in Cancer, ISSN 0941-4355, 3/2016, Volume 24, Issue 3, pp. 1019 - 1024
Our aim is to test the validity, reliability, and acceptability of the Chinese version of European Organization for Research and Treatment of Cancer Quality of...
Validation | Health-related quality of life | Pain Medicine | EORTC QLQ-BM22 | Nursing | Rehabilitation Medicine | Medicine & Public Health | Oncology | Bone metastases | Nursing Management/Nursing Research | EUROPEAN ORGANIZATION | RELIABILITY | CANCER | MODULE | ONCOLOGY | HEALTH CARE SCIENCES & SERVICES | REHABILITATION | QUALITY-OF-LIFE | QUESTIONNAIRE | VALIDITY | Humans | Middle Aged | Bone Density Conservation Agents - therapeutic use | Bone Neoplasms - secondary | Male | Young Adult | Asian Continental Ancestry Group | Validation Studies as Topic | Aged, 80 and over | Quality of Life | Adult | Female | Surveys and Questionnaires | Aged | Patient Compliance | Care and treatment | Cancer patients | Metastasis | Analysis | Bones | Questionnaires | Cancer | Quality of life
Validation | Health-related quality of life | Pain Medicine | EORTC QLQ-BM22 | Nursing | Rehabilitation Medicine | Medicine & Public Health | Oncology | Bone metastases | Nursing Management/Nursing Research | EUROPEAN ORGANIZATION | RELIABILITY | CANCER | MODULE | ONCOLOGY | HEALTH CARE SCIENCES & SERVICES | REHABILITATION | QUALITY-OF-LIFE | QUESTIONNAIRE | VALIDITY | Humans | Middle Aged | Bone Density Conservation Agents - therapeutic use | Bone Neoplasms - secondary | Male | Young Adult | Asian Continental Ancestry Group | Validation Studies as Topic | Aged, 80 and over | Quality of Life | Adult | Female | Surveys and Questionnaires | Aged | Patient Compliance | Care and treatment | Cancer patients | Metastasis | Analysis | Bones | Questionnaires | Cancer | Quality of life
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2008, Volume 45, Issue 7, pp. 1146 - 1152
Abstract Aim The aim of this study was to develop a bone metastases module to supplement the European Organisation for Research and Treatment of Cancer Core...
Hematology, Oncology and Palliative Medicine | Health-related quality of life | Pain symptoms | Questionnaire | EORTC | Bone metastases | Cancer | ORAL CLODRONATE | CONTROLLED-TRIAL | PLACEBO | IBANDRONATE | SUPPORTIVE PAMIDRONATE TREATMENT | BREAST-CANCER | ZOLEDRONIC ACID | PAIN | ONCOLOGY | PROSTATE-CANCER | CARCINOMA | Bone Neoplasms - psychology | Guidelines as Topic | Health Status Indicators | Europe | Humans | Middle Aged | Patient Participation | Bone Neoplasms - secondary | Male | Psychometrics | Neoplasms - psychology | Aged, 80 and over | Quality of Life | Adult | Female | Interviews as Topic | Aged | Surveys and Questionnaires - standards
Hematology, Oncology and Palliative Medicine | Health-related quality of life | Pain symptoms | Questionnaire | EORTC | Bone metastases | Cancer | ORAL CLODRONATE | CONTROLLED-TRIAL | PLACEBO | IBANDRONATE | SUPPORTIVE PAMIDRONATE TREATMENT | BREAST-CANCER | ZOLEDRONIC ACID | PAIN | ONCOLOGY | PROSTATE-CANCER | CARCINOMA | Bone Neoplasms - psychology | Guidelines as Topic | Health Status Indicators | Europe | Humans | Middle Aged | Patient Participation | Bone Neoplasms - secondary | Male | Psychometrics | Neoplasms - psychology | Aged, 80 and over | Quality of Life | Adult | Female | Interviews as Topic | Aged | Surveys and Questionnaires - standards
Journal Article
Quality of Life Research, ISSN 0962-9343, 10/2016, Volume 25, Issue 10, pp. 2535 - 2541
Validated tools for evaluating quality of life (QOL) in patients with bone metastases include the EORTC QLQ-BM22 and QLQ-C15-PAL modules. A statistically...
Public Health | Medicine & Public Health | EORTC QLQ-C15-PAL module | Radiation | Quality of Life Research | EORTC QLQ-BM22 module | Minimal clinically important differences | Sociology, general | Bone metastases | REPORTED OUTCOMES | MEANINGFUL CHANGE | INSTRUMENT | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | CANCER-PATIENTS | THERAPY | SCORES | HEALTH CARE SCIENCES & SERVICES | HEALTH POLICY & SERVICES | QLQ-C30 | QUALITY-OF-LIFE | EUROPEAN-ORGANIZATION | QUESTIONNAIRE | Prospective Studies | Sickness Impact Profile | Humans | Middle Aged | Bone Neoplasms - secondary | Male | Palliative Care | Bone Neoplasms - radiotherapy | Neoplasm Metastasis | Aged, 80 and over | Adult | Female | Surveys and Questionnaires | Aged | Minimal Clinically Important Difference | Care and treatment | Metastasis | Radiotherapy | Analysis | Palliative care | Bone cancer | Radiation therapy | Quality of life
Public Health | Medicine & Public Health | EORTC QLQ-C15-PAL module | Radiation | Quality of Life Research | EORTC QLQ-BM22 module | Minimal clinically important differences | Sociology, general | Bone metastases | REPORTED OUTCOMES | MEANINGFUL CHANGE | INSTRUMENT | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | CANCER-PATIENTS | THERAPY | SCORES | HEALTH CARE SCIENCES & SERVICES | HEALTH POLICY & SERVICES | QLQ-C30 | QUALITY-OF-LIFE | EUROPEAN-ORGANIZATION | QUESTIONNAIRE | Prospective Studies | Sickness Impact Profile | Humans | Middle Aged | Bone Neoplasms - secondary | Male | Palliative Care | Bone Neoplasms - radiotherapy | Neoplasm Metastasis | Aged, 80 and over | Adult | Female | Surveys and Questionnaires | Aged | Minimal Clinically Important Difference | Care and treatment | Metastasis | Radiotherapy | Analysis | Palliative care | Bone cancer | Radiation therapy | Quality of life
Journal Article
Radiotherapy and Oncology, ISSN 0167-8140, 2016, Volume 119, Issue 2, pp. 208 - 212
Abstract Purpose Quality of life (QOL) can be compromised in patients with bone metastases, and validated QOL instruments are required to accurately measure...
Hematology, Oncology and Palliative Medicine | Validation | EORTC QLQ-BM22 module | EORTC QLQ-C15-PAL instrument | Bone metastases | Radiation | CANCER | ONCOLOGY | CLINICAL-TRIALS | QUALITY-OF-LIFE | EUROPEAN-ORGANIZATION | QLQ-C15-PAL | QUESTIONNAIRE | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Reproducibility of Results | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Bone Neoplasms - secondary | Male | Bone Neoplasms - complications | Canada | Bone Neoplasms - radiotherapy | Aged, 80 and over | Pain - etiology | Quality of Life | Adult | Female | Surveys and Questionnaires | Aged | Palliative Care - methods | Medicine, Experimental | Medical research | Care and treatment | Metastasis | Radiotherapy | Analysis
Hematology, Oncology and Palliative Medicine | Validation | EORTC QLQ-BM22 module | EORTC QLQ-C15-PAL instrument | Bone metastases | Radiation | CANCER | ONCOLOGY | CLINICAL-TRIALS | QUALITY-OF-LIFE | EUROPEAN-ORGANIZATION | QLQ-C15-PAL | QUESTIONNAIRE | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Reproducibility of Results | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Bone Neoplasms - secondary | Male | Bone Neoplasms - complications | Canada | Bone Neoplasms - radiotherapy | Aged, 80 and over | Pain - etiology | Quality of Life | Adult | Female | Surveys and Questionnaires | Aged | Palliative Care - methods | Medicine, Experimental | Medical research | Care and treatment | Metastasis | Radiotherapy | Analysis
Journal Article
Cancer, ISSN 0008-543X, 03/2012, Volume 118, Issue 5, pp. 1457 - 1465
BACKGROUND: The objective of this international field study was to test the reliability, validity, and responsiveness of the European Organization for Research...
bone metastases | health‐related quality of life | clinical trials | European Organization for Research and Treatment of Cancer (EORTC) QLQ‐BM22 | health-related quality of life | European Organization for Research and Treatment of Cancer (EORTC) QLQ-BM22 | ONCOLOGY | CLINICAL-TRIALS | EUROPEAN-ORGANIZATION | QUESTIONNAIRE | Geography | Prognosis | Health Status Indicators | Humans | Middle Aged | Bone Neoplasms - secondary | Male | Medical Oncology - organization & administration | Societies, Medical | Bone Neoplasms - physiopathology | Sensitivity and Specificity | Adult | Female | Surveys and Questionnaires | Quality of Life - psychology | Carcinoma - secondary | Bone Neoplasms - psychology | Medical Oncology - methods | Reproducibility of Results | Bone Neoplasms - diagnosis | Carcinoma - diagnosis | Carcinoma - psychology | Carcinoma - physiopathology | Internationality | Aged | Health Status | Clinical trials | Care and treatment | Bone diseases | Diagnosis | Methods
bone metastases | health‐related quality of life | clinical trials | European Organization for Research and Treatment of Cancer (EORTC) QLQ‐BM22 | health-related quality of life | European Organization for Research and Treatment of Cancer (EORTC) QLQ-BM22 | ONCOLOGY | CLINICAL-TRIALS | EUROPEAN-ORGANIZATION | QUESTIONNAIRE | Geography | Prognosis | Health Status Indicators | Humans | Middle Aged | Bone Neoplasms - secondary | Male | Medical Oncology - organization & administration | Societies, Medical | Bone Neoplasms - physiopathology | Sensitivity and Specificity | Adult | Female | Surveys and Questionnaires | Quality of Life - psychology | Carcinoma - secondary | Bone Neoplasms - psychology | Medical Oncology - methods | Reproducibility of Results | Bone Neoplasms - diagnosis | Carcinoma - diagnosis | Carcinoma - psychology | Carcinoma - physiopathology | Internationality | Aged | Health Status | Clinical trials | Care and treatment | Bone diseases | Diagnosis | Methods
Journal Article
Quality of Life Research, ISSN 0962-9343, 3/2014, Volume 23, Issue 2, pp. 527 - 532
Purpose The aim of our study was to undertake a prospective validation study of the Polish version of the European Organization for Research and Treatment of...
Discriminants | Health outcomes | Correlation coefficients | Questionnaires | Research organizations | Clinical trials | Bones | Psychometrics | Oncology | Quality of life | Validation | Public Health | Medicine & Public Health | EORTC | Quality of Life Research | QLQ-BM22 | Sociology, general | Bone metastases | CANCER CLINICAL-TRIALS | REPORTED OUTCOMES | EUROPEAN ORGANIZATION | TRANSLATION | ISSUES | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | ONCOLOGY | HEALTH CARE SCIENCES & SERVICES | HEALTH POLICY & SERVICES | QLQ-C30 | Bone Neoplasms - psychology | Reproducibility of Results | Prospective Studies | Humans | Middle Aged | Bone Neoplasms - secondary | Male | Poland | Quality of Life | Female | Surveys and Questionnaires | Health Status | Translations | Care and treatment | Metastasis | Measurement
Discriminants | Health outcomes | Correlation coefficients | Questionnaires | Research organizations | Clinical trials | Bones | Psychometrics | Oncology | Quality of life | Validation | Public Health | Medicine & Public Health | EORTC | Quality of Life Research | QLQ-BM22 | Sociology, general | Bone metastases | CANCER CLINICAL-TRIALS | REPORTED OUTCOMES | EUROPEAN ORGANIZATION | TRANSLATION | ISSUES | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | ONCOLOGY | HEALTH CARE SCIENCES & SERVICES | HEALTH POLICY & SERVICES | QLQ-C30 | Bone Neoplasms - psychology | Reproducibility of Results | Prospective Studies | Humans | Middle Aged | Bone Neoplasms - secondary | Male | Poland | Quality of Life | Female | Surveys and Questionnaires | Health Status | Translations | Care and treatment | Metastasis | Measurement
Journal Article
Supportive Care in Cancer, ISSN 0941-4355, 12/2012, Volume 20, Issue 12, pp. 3307 - 3313
Quality of life (QOL) is frequently an endpoint in clinical trials involving patients with advanced cancer. Statistical significance of minimal differences can...
Pain Medicine | EORTC QLQ-BM22 | Rehabilitation Medicine | Nursing | Medicine & Public Health | Oncology | Minimal clinically important difference | Bone metastases | Nursing Management/Nursing Research | Quality of life | EORTC QLQ-C30 | ANCHOR | TRIALS | REPORTED OUTCOMES | MEANINGFUL CHANGE | ONCOLOGY | SCORES | HEALTH CARE SCIENCES & SERVICES | SCALES | REHABILITATION | QUALITY-OF-LIFE | EUROPEAN-ORGANIZATION | QUESTIONNAIRE | Outcome Assessment (Health Care) - methods | Bone Neoplasms - psychology | Prospective Studies | Humans | Middle Aged | Psychometrics - instrumentation | Bone Neoplasms - secondary | Fatigue - etiology | Male | Bone Neoplasms - complications | Karnofsky Performance Status | Aged, 80 and over | Pain - etiology | Quality of Life | Adult | Female | Surveys and Questionnaires | Aged | Cancer patients | Care and treatment | Metastasis | Research | Analysis | Bones | Cancer
Pain Medicine | EORTC QLQ-BM22 | Rehabilitation Medicine | Nursing | Medicine & Public Health | Oncology | Minimal clinically important difference | Bone metastases | Nursing Management/Nursing Research | Quality of life | EORTC QLQ-C30 | ANCHOR | TRIALS | REPORTED OUTCOMES | MEANINGFUL CHANGE | ONCOLOGY | SCORES | HEALTH CARE SCIENCES & SERVICES | SCALES | REHABILITATION | QUALITY-OF-LIFE | EUROPEAN-ORGANIZATION | QUESTIONNAIRE | Outcome Assessment (Health Care) - methods | Bone Neoplasms - psychology | Prospective Studies | Humans | Middle Aged | Psychometrics - instrumentation | Bone Neoplasms - secondary | Fatigue - etiology | Male | Bone Neoplasms - complications | Karnofsky Performance Status | Aged, 80 and over | Pain - etiology | Quality of Life | Adult | Female | Surveys and Questionnaires | Aged | Cancer patients | Care and treatment | Metastasis | Research | Analysis | Bones | Cancer
Journal Article
Asian Pacific Journal of Cancer Prevention, ISSN 1513-7368, 04/2016, Volume 17, Issue 3, pp. 1405 - 1410
Journal Article
Expert Review of Pharmacoeconomics & Outcomes Research, ISSN 1473-7167, 04/2012, Volume 12, Issue 2, pp. 213 - 219
Introduction: Maintenance or improvement in quality of life (QoL) is the main goal of palliative treatments for bone metastases. Validated and comprehensive...
bone metastases | FACT-BP | EORTC QLQ-BM22 | advanced cancer | quality of life | FUNCTIONAL ASSESSMENT | VALIDATION | SKELETAL-RELATED EVENT | BRAIN CANCER | PALLIATIVE BENEFIT | THERAPY | HEALTH CARE SCIENCES & SERVICES | PHARMACOLOGY & PHARMACY | HEALTH POLICY & SERVICES
bone metastases | FACT-BP | EORTC QLQ-BM22 | advanced cancer | quality of life | FUNCTIONAL ASSESSMENT | VALIDATION | SKELETAL-RELATED EVENT | BRAIN CANCER | PALLIATIVE BENEFIT | THERAPY | HEALTH CARE SCIENCES & SERVICES | PHARMACOLOGY & PHARMACY | HEALTH POLICY & SERVICES
Journal Article
Expert Review of Pharmacoeconomics & Outcomes Research, ISSN 1473-7167, 02/2014, Volume 14, Issue 1, pp. 147 - 156
The aim of the present study was to evaluate the psychometric properties of the measure among a sample of Iranian patients with bone metastases. One hundred...
bone metastases | health-related quality of life | multigroup confirmatory factor analysis | European Organisation for Research and Treatment of Cancer (EORTC) QLQ-BM22 | factor structure | Factor structure | Health-related quality of life | Multigroup confirmatory factor analysis | Bone metastases | PAIN | ONCOLOGY | CLINICAL-TRIALS | HEALTH CARE SCIENCES & SERVICES | GENDER | PHARMACOLOGY & PHARMACY | HEALTH POLICY & SERVICES | QLQ-C30
bone metastases | health-related quality of life | multigroup confirmatory factor analysis | European Organisation for Research and Treatment of Cancer (EORTC) QLQ-BM22 | factor structure | Factor structure | Health-related quality of life | Multigroup confirmatory factor analysis | Bone metastases | PAIN | ONCOLOGY | CLINICAL-TRIALS | HEALTH CARE SCIENCES & SERVICES | GENDER | PHARMACOLOGY & PHARMACY | HEALTH POLICY & SERVICES | QLQ-C30
Journal Article
Asia‐Pacific Journal of Clinical Oncology, ISSN 1743-7555, 06/2014, Volume 10, Issue 2, pp. 118 - 123
Aims Bone metastases are a common complication of advanced cancer and often result in a decrease in patients' quality of life. Very few specific modules have...
bone metastases | EORTC QLQ‐C30 | quality of life | BOMET‐QOL | EORTC QLQ‐BM22 | EORTC QLQ-BM22 | BOMET-QOL | Bone metastases | EORTC QLQ-C30 | Quality of life | ONCOLOGY | Bone Neoplasms - psychology | Neoplasm Metastasis | Bone Neoplasms - physiopathology | Humans | Bone Neoplasms - secondary | Quality of Life | Surveys and Questionnaires | Neoplasms - psychology | Neoplasms - pathology | Surveys | Complications and side effects | Care and treatment | Metastasis | Comparative analysis
bone metastases | EORTC QLQ‐C30 | quality of life | BOMET‐QOL | EORTC QLQ‐BM22 | EORTC QLQ-BM22 | BOMET-QOL | Bone metastases | EORTC QLQ-C30 | Quality of life | ONCOLOGY | Bone Neoplasms - psychology | Neoplasm Metastasis | Bone Neoplasms - physiopathology | Humans | Bone Neoplasms - secondary | Quality of Life | Surveys and Questionnaires | Neoplasms - psychology | Neoplasms - pathology | Surveys | Complications and side effects | Care and treatment | Metastasis | Comparative analysis
Journal Article
Anticancer Research, ISSN 0250-7005, 08/2018, Volume 38, Issue 8, pp. 4953 - 4960
Background/Aim: Quality of life (QOL) is becoming increasingly important to appraise the value of a particular oncologic intervention. This was a prespecified...
Intensity-modulated radiotherapy | Palliative radiotherapy | Toxicity | Spinal metastases | Quality of life | toxicity | IRRADIATION | intensity-modulated radiotherapy | EORTC QLQ-BM22 | CANCER-RELATED FATIGUE | THERAPY | MODELS | ONCOLOGY | PROSTATE-CANCER | quality of life | palliative radiotherapy | QUESTIONNAIRE | Index Medicus
Intensity-modulated radiotherapy | Palliative radiotherapy | Toxicity | Spinal metastases | Quality of life | toxicity | IRRADIATION | intensity-modulated radiotherapy | EORTC QLQ-BM22 | CANCER-RELATED FATIGUE | THERAPY | MODELS | ONCOLOGY | PROSTATE-CANCER | quality of life | palliative radiotherapy | QUESTIONNAIRE | Index Medicus
Journal Article
Quality of Life Research, ISSN 0962-9343, 8/2018, Volume 27, Issue 8, pp. 1937 - 1955
Patient-reported outcome measures (PROMs) are becoming increasingly important in clinical practice. The implementation of PROMS in routine practice is...
Public Health | Medicine & Public Health | Quality of Life Research | Quality of Life | Palliative care | Medical oncology | Patient-reported outcomes | Sociology, general | Validation studies | QUESTIONNAIRE QLQ-C30 | BONE METASTASES | REPORTED OUTCOME MEASURES | RANDOMIZED CONTROLLED-TRIAL | PALLIATIVE CARE POPULATION | CELL LUNG-CANCER | SYMPTOM ASSESSMENT SCALE | CLINICALLY IMPORTANT DIFFERENCES | EORTC QLQ-BM22 | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | HEALTH CARE SCIENCES & SERVICES | HEALTH POLICY & SERVICES | EUROPEAN-ORGANIZATION | Measurement | Medical research | Cancer patients | Measuring instruments | Medicine, Experimental | Palliative treatment | Cancer | Clinical medicine | Quantitative psychology | Quality
Public Health | Medicine & Public Health | Quality of Life Research | Quality of Life | Palliative care | Medical oncology | Patient-reported outcomes | Sociology, general | Validation studies | QUESTIONNAIRE QLQ-C30 | BONE METASTASES | REPORTED OUTCOME MEASURES | RANDOMIZED CONTROLLED-TRIAL | PALLIATIVE CARE POPULATION | CELL LUNG-CANCER | SYMPTOM ASSESSMENT SCALE | CLINICALLY IMPORTANT DIFFERENCES | EORTC QLQ-BM22 | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | HEALTH CARE SCIENCES & SERVICES | HEALTH POLICY & SERVICES | EUROPEAN-ORGANIZATION | Measurement | Medical research | Cancer patients | Measuring instruments | Medicine, Experimental | Palliative treatment | Cancer | Clinical medicine | Quantitative psychology | Quality
Journal Article
Gan to kagaku ryoho. Cancer & chemotherapy, ISSN 0385-0684, 08/2010, Volume 37, Issue 8, pp. 1507 - 1512
Journal Article
Quality of Life Research, ISSN 0962-9343, 4/2018, Volume 27, Issue 4, pp. 1089 - 1098
The EORTC QLQ-C30 and the Brief Pain Inventory (BPI) are validated tools for measuring quality of life (QOL) and the impact of pain in patients with advanced...
Public Health | Medicine & Public Health | Brief pain inventory | Radiation | Quality of Life Research | Minimal clinically important differences | Sociology, general | Bone metastases | EORTC QLQ-C30 | TRIALS | QLQ-BM22 | PREVALENCE | PALLIATIVE RADIOTHERAPY | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | CANCER-PATIENTS | SCORES | HEALTH CARE SCIENCES & SERVICES | HEALTH POLICY & SERVICES | QUALITY-OF-LIFE | QLQ-C15-PAL | QUESTIONNAIRE | Prospective Studies | Humans | Middle Aged | Re-Irradiation - adverse effects | Bone Neoplasms - secondary | Male | Bone Neoplasms - complications | Young Adult | Bone Neoplasms - radiotherapy | Adolescent | Aged, 80 and over | Adult | Female | Surveys and Questionnaires | Aged | Quality of Life - psychology | Minimal Clinically Important Difference | Pain - diagnosis | Metastasis | Studies | Pain | Bones | Quantitative psychology | Cancer | Quality of life
Public Health | Medicine & Public Health | Brief pain inventory | Radiation | Quality of Life Research | Minimal clinically important differences | Sociology, general | Bone metastases | EORTC QLQ-C30 | TRIALS | QLQ-BM22 | PREVALENCE | PALLIATIVE RADIOTHERAPY | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | CANCER-PATIENTS | SCORES | HEALTH CARE SCIENCES & SERVICES | HEALTH POLICY & SERVICES | QUALITY-OF-LIFE | QLQ-C15-PAL | QUESTIONNAIRE | Prospective Studies | Humans | Middle Aged | Re-Irradiation - adverse effects | Bone Neoplasms - secondary | Male | Bone Neoplasms - complications | Young Adult | Bone Neoplasms - radiotherapy | Adolescent | Aged, 80 and over | Adult | Female | Surveys and Questionnaires | Aged | Quality of Life - psychology | Minimal Clinically Important Difference | Pain - diagnosis | Metastasis | Studies | Pain | Bones | Quantitative psychology | Cancer | Quality of life
Journal Article
Journal of Pain Management, ISSN 1939-5914, 2009, Volume 2, Issue 4, pp. 445 - 452
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2016, Volume 95, Issue 5, pp. 1391 - 1398
Purpose To study the course of quality of life (QoL) after radiation therapy for painful bone metastases. Patients and Methods The Dutch Bone Metastasis Study...
Radiology | Hematology, Oncology and Palliative Medicine | PALLIATIVE RADIOTHERAPY | EORTC QLQ-BM22 | ONCOLOGY | RANDOMIZED-TRIAL | EUROPEAN-ORGANIZATION | ADVANCED CANCER-PATIENTS | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Bone Neoplasms - psychology | Pain - prevention & control | Humans | Middle Aged | Netherlands - epidemiology | Bone Neoplasms - secondary | Analgesics, Opioid - therapeutic use | Male | Treatment Outcome | Radiotherapy, Conformal - psychology | Bone Neoplasms - radiotherapy | Pain - psychology | Aged, 80 and over | Adult | Female | Aged | Quality of Life - psychology | Pain - diagnosis | Palliative Care - methods | Care and treatment | Metastasis | Radiotherapy | Analysis | Radiation | Medical research | Medicine, Experimental | PATIENTS | RADIOLOGY AND NUCLEAR MEDICINE | SURVIVAL TIME | RADIOTHERAPY | STANDARD OF LIVING | GY RANGE 01-10
Radiology | Hematology, Oncology and Palliative Medicine | PALLIATIVE RADIOTHERAPY | EORTC QLQ-BM22 | ONCOLOGY | RANDOMIZED-TRIAL | EUROPEAN-ORGANIZATION | ADVANCED CANCER-PATIENTS | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Bone Neoplasms - psychology | Pain - prevention & control | Humans | Middle Aged | Netherlands - epidemiology | Bone Neoplasms - secondary | Analgesics, Opioid - therapeutic use | Male | Treatment Outcome | Radiotherapy, Conformal - psychology | Bone Neoplasms - radiotherapy | Pain - psychology | Aged, 80 and over | Adult | Female | Aged | Quality of Life - psychology | Pain - diagnosis | Palliative Care - methods | Care and treatment | Metastasis | Radiotherapy | Analysis | Radiation | Medical research | Medicine, Experimental | PATIENTS | RADIOLOGY AND NUCLEAR MEDICINE | SURVIVAL TIME | RADIOTHERAPY | STANDARD OF LIVING | GY RANGE 01-10
Journal Article